The positron emission tomography with F18 17β-estradiol has the potential to benefit diagnosis and treatment of endometrial cancer

Material type: 文書・図像類

Author: YOSHIDA, Yoshioほか

Publisher: Elsevier

Publication date: 2007-03

Material Format: Digital

Capacity, size, etc.: -

NDC: -

View All

Notes on use

Note (General)：: Background. The positron emission tomography (PET) with F18 17β-estradiol (FES) has good imaging for assessment of estrogen receptor in breast cancer....

Search by Bookstore

Holdings of Libraries in Japan

This page shows libraries in Japan other than the National Diet Library that hold the material.

List of Cooperating Institutions and Databases

Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.

other

Ｕｎｉｖｅｒｓｉｔｙ　ｏｆ　Ｆｕｋｕｉ　Ａｃａｄｅｍｉｃ　Ｒｅｐｏｓｉｔｏｒｙ
Digital
You can check the holdings of institutions and databases with which Institutional Repositories DataBase(IRDB)(Institutional Repository) is linked at the site of Institutional Repositories DataBase(IRDB)(Institutional Repository).
Ｕｎｉｖｅｒｓｉｔｙ　ｏｆ　Ｆｕｋｕｉ　Ａｃａｄｅｍｉｃ　Ｒｅｐｏｓｉｔｏｒｙ

Search by Bookstore

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type: 文書・図像類
Title: The positron emission tomography with F18 17β-estradiol has the potential to benefit diagnosis and treatment of endometrial cancer
Author/Editor: YOSHIDA, Yoshio
KUROKAWA, Tetsuji
SAWAMURA, Yoko
SHINAGAWA, Akiko
OKAZAWA, Hidehiko
FUJIBAYASHI, Yasuhisa
KOTSUJI, Fumikazu
Author Heading: YOSHIDA, Yoshio
KUROKAWA, Tetsuji
SAWAMURA, Yoko
SHINAGAWA, Akiko
OKAZAWA, Hidehiko
FUJIBAYASHI, Yasuhisa
KOTSUJI, Fumikazu
Publication, Distribution, etc.: Elsevier
Publication Date: 2007-03
Publication Date (W3CDTF): 2007-03
Periodical title: Gynecologic oncology
No. or year of volume/issue: 104 3
Volume: 104
Issue: 3
Pages: 764-766
Text Language Code: eng
Subject Heading: FES-PET
Endometrial cancer
Endocrine treatment
Target Audience: 一般
Note (General): Background. The positron emission tomography (PET) with F18 17β-estradiol (FES) has good imaging for assessment of estrogen receptor in breast cancer. Case. We report on a 30-year-old woman who desired to preserve her fertility with well-differentiated endometrial adenocarcinoma. Before hormone treatment was started, FES-PET showed increased uptake of endometrium, magnetic resonance imaging (MRI) showed thickness and F- 18 fluorodeoxyglucose (FDG)-PET showed increased uptake. FES-PET after 3 months showed remaining FES uptake, but there were no abnormal findings on MRI and FDG-PET. Hysteroscopy showed remaining adenocarcinoma. After additional treatment, FES-PET showed a therapeutic response, and hysteroscopy showed no abnormal finding. Conclusions. To our knowledge, this is the first report that FES-PET has the potential to provide more useful information than did FDG-PET about the hormone therapy.
Access Restrictions: 限定公開
Related Material (DOI): 10.024
Data Provider (Database): 国立情報学研究所 : 学術機関リポジトリデータベース（IRDB）（機関リポジトリ）
https://irdb.nii.ac.jp
Original Data Provider (Database): 福井大学 : 福井大学学術機関リポジトリ